24 out of the 103 different adverse outcomes analysed showed a statistically and practically significant increase in patients receiving a bisphosphonate drug compared with those not (2 additional outcomes that appeared statistically significant came only from small studies with low event counts and no clinical suspicion so are likely artifacts).
← all excerpts
The adverse effects of bisphosphonates in breast cancer: A systematic review and network meta-analysis.
1
—
—